Remco A. De Vrueh - Publications

Detection and analysis of Serpin and RP26 specific antibodies for monitoring Schistosoma haematobium transmission.

Journal: PLoS neglected tropical diseases

Published: September 26, 2024

From Innovator Result-driven to Multi-actor Impact-oriented Public-Private Partnerships: Integrating the Patient Perspective.

Journal: Handbook of experimental pharmacology

Published: September 05, 2024

UNITE4TB: a new consortium for clinical drug and regimen development for TB.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: October 23, 2021

Potential of antibody test using Schistosoma mansoni recombinant serpin and RP26 to detect light-intensity infections in endemic areas.

Journal: Parasitology international

Published: November 25, 2020

Editorial: Public-Private Partnerships as Drivers of Innovation in Healthcare.

Journal: Frontiers in medicine

Published: May 02, 2019

Reflections on the Future of Pharmaceutical Public-Private Partnerships: From Input to Impact.

Journal: Pharmaceutical research

Published: March 22, 2017

Product development programs for neglected tropical diseases: A crucial role for expert meetings.

Journal: PLoS neglected tropical diseases

Published: February 24, 2017

Drug development for exceptionally rare metabolic diseases: challenging but not impossible.

Journal: Orphanet journal of rare diseases

Published: June 28, 2013

Towards the harmonization of outcome measures in children with mitochondrial disorders.

Journal: Developmental medicine and child neurology

Published: January 02, 2013